Racette, Susan B <br/><br/>
Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus.  [electronic resource] 

 -  Metabolism: clinical and experimental  Feb 2002 
 - 169-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1053/meta.2002.29981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--drug effects<br/>Blood Glucose--analysis<br/>Chromans--pharmacology<br/>Diabetes Mellitus, Type 2--blood<br/>Fatty Acids, Nonesterified--metabolism<br/>Female<br/>Glucose--administration & dosage<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--administration & dosage<br/>Male<br/>Middle Aged<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Troglitazone